2023

Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma
Knörr F, Schellekens K, Schoot R, Landman-Parker J, Teltschik H, Förster J, Riquelme A, Huitema A, Van Eijkelenburg N, Beishuizen A, Zwaan C, Woessmann W, Van der Lugt J
HAEMATOLOGICA. 2023;108(5):1442-1446.

Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma - Response
Knörr F, Woessmann W
BRIT J HAEMATOL. 2023;200(1):107-108.

Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents
Rigaud C, Knörr F, Brugières L, Woessmann W
BEST PRACT RES CL HA. 2023;36(1):101444.

2022

Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?
Damm-Welk C, Lovisa F, Contarini G, Lüdersen J, Carraro E, Knörr F, Förster J, Zimmermann M, Sala A, Vinti L, Tondo A, Pillon M, Woessmann W, Mussolin L
CANCERS. 2022;14(7):.

Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
Möker P, Zur Stadt U, Zimmermann M, Alawi M, Mueller S, Finger J, Knörr F, Riquelme A, Oschlies I, Klapper W, Bradtke J, Burkhardt B, Woessmann W, Damm-Welk C
LEUKEMIA. 2022;36(9):2343-2346.

2021

Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma
Knörr F, Zimmermann M, Attarbaschi A, Kabickova E, Maecker-Kolhoff B, Ruf S, Kühnle I, Ebinger M, Garthe A, Simonitsch-Klupp I, Oschlies I, Klapper W, Burkhardt B, Wößmann W
HAEMATOLOGICA. 2021;106(12):3232-3235.

Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma
Liang H, Costanza M, Prutsch N, Zimmerman M, Gurnhofer E, Montes-Mojarro I, Abraham B, Prokoph N, Stoiber S, Tangermann S, Lobello C, Oppelt J, Anagnostopoulos I, Hielscher T, Pervez S, Klapper W, Zammarchi F, Silva D, Garcia K, Baker D, Janz M, Schleussner N, Fend F, Pospíšilová Š, Janiková A, Wallwitz J, Stoiber D, Simonitsch-Klupp I, Cerroni L, Pileri S, de Leval L, Sibon D, Fataccioli V, Gaulard P, Assaf C, Knörr F, Damm-Welk C, Woessmann W, Turner S, Look A, Mathas S, Kenner L, Merkel O
NAT COMMUN. 2021;12(1):.

2020

Quantification of minimal disseminated disease by quantitative PCR and digital PCR for NPM-ALK as prognostic factor in children with anaplastic large cell lymphoma
Damm-Welk C, Kutscher N, Zimmermann M, Attarbaschi A, Schieferstein J, Knörr F, Oschlies I, Klapper W, Woessmann W
HAEMATOLOGICA. 2020;105(8):2141-2149.

Stem Cell Transplantation and Vinblastine Monotherapy for Relapsed Pediatric Anaplastic Large Cell Lymphoma: Results of the International, Prospective ALCL-Relapse Trial
Knörr F, Brugières L, Pillon M, Zimmermann M, Ruf S, Attarbaschi A, Mellgren K, Burke G, Uyttebroeck A, Wróbel G, Beishuizen A, Aladjidi N, Reiter A, Woessmann W
J CLIN ONCOL. 2020;38(34):3999-4009.

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy
Woessmann W, Zimmermann M, Meinhardt A, Müller S, Hauch H, Knörr F, Oschlies I, Klapper W, Niggli F, Kabickova E, Attarbaschi A, Reiter A, Burkhardt B
BLOOD. 2020;135(14):1124-1132.

2018

Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma
Knörr F, Damm-Welk C, Ruf S, Singh V, Zimmermann M, Reiter A, Woessmann W
HAEMATOLOGICA. 2018;103(3):477-485.

Epitope mapping of anti-ALK antibodies in children with anaplastic large cell lymphoma
Knörr F, Weber S, Singh V, Pulford K, Reiter A, Woessmann W, Damm-Welk C
CLIN IMMUNOL. 2018;195:77-81.

Course of anti-ALK antibody titres during chemotherapy in children with anaplastic large cell lymphoma
Mussolin L, Pillon M, Zimmermann M, Carraro E, Basso G, Knoerr F, Woessmann W, Damm-Welk C
BRIT J HAEMATOL. 2018;182(5):733-735.

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
Stadler S, Singh V, Knörr F, Damm-Welk C, Woessmann W
CANCERS. 2018;10(4):.

Letzte Aktualisierung aus dem FIS: 28.11.2024 - 03:32 Uhr